Acelyrin Inc
(SLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 105,112 | 94,423 | 42,696 | 179,833 | 22,812 |
| Operating Income | -105,112 | -94,423 | -42,696 | -179,833 | -22,812 |
| Other Income | 9,900 | 10,483 | 16,657 | 3,383 | 3,005 |
| Pre-tax Income | -95,212 | -83,940 | -26,039 | -176,450 | -19,807 |
| Net Income Continuous | -95,212 | -83,940 | -26,039 | -176,450 | -19,807 |
| Net Income | $-95,212 | $-83,940 | $-26,039 | $-176,450 | $-19,807 |
| EPS Basic Total Ops | 4.45 | -0.87 | -0.40 | -8.61 | -6.41 |
| EPS Basic Continuous Ops | 4.44 | -0.87 | -0.40 | -8.61 | -6.42 |
| EPS Diluted Total Ops | 4.45 | -0.87 | -0.40 | -8.61 | -6.41 |
| EPS Diluted Continuous Ops | 4.44 | -0.87 | -0.40 | -8.61 | -6.42 |
| EPS Diluted Before Non-Recurring Items | -0.75 | -0.87 | -0.56 | N/A | N/A |
| EBITDA(a) | $-109,995 | $-99,036 | $-43,403 | $-180,010 | $-23,136 |